Duration of treatment: One day

3 trials

Sponsors

Intas Pharmaceuticals Ltd, PNB Vesper Life Science Pvt Ltd

Phase 1

A pharmacokinetic and pharmacodynamic study of pegfilgrastim (test drug) with Neulasta of Amgen (reference drug, EU Licensed Product) in normal adult human subjects under fasting conditions.

Active, not recruitingCTRI/2016/07/007096

Intas Pharmaceuticals Ltd

Target: 344Updated: 2021-11-24

A Study of PNB-001 in Healthy, Adult, Human Male Subjects Under Fasting Conditions

Active, not recruitingCTRI/2018/08/015297

PNB Vesper Life Science Pvt Ltd

Target: 42Updated: 2021-11-24

Unknown Phase

A Study of Injections of Pegfilgrastim in Healthy, Adult Human Subjects.

Active, not recruitingCTRI/2018/02/011700

Intas Pharmaceuticals Ltd

Target: 144Updated: 2021-11-24